General Information of Drug Formulation (ID: F21204)

Formulation Name
Tolvaptan 15 mg tablet
Company
Otsuka America Pharmaceutical
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Tolvaptan DMIWFRL Autosomal dominant polycystic kidney disease GB81 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
FD&C blue no. 2 E00446 2723854 Colorant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant